Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma

Diseases of the Esophagus

Volumn 25, Issue 7, 2012, Pages 638-644

  Hang, D ^a   Dong, H C ^b   Ning, T ^a   Dong, B ^a   Hou, D L ^a   Xu, W G ^b  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b HEBEI UNITED UNIVERSITY   (China)

Author keywords

ABCG2; CD133; Esophageal squamous cell cancer; Immunohistochemistry; Prognosis

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PEPTIDES; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84861018126     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01298.x     Document Type: Article

References (30)

1. Jemal A, Bray F, Center M M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Tepper J, Krasna M J, Niedzwiecki D etal. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26 (7): 1086-92.
3. Al-Hajj M, Wicha M S, Benito-Hernandez A, Morrison S J, Clarke M F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-8.
4. Singh S K, Hawkins C, Clarke I D etal. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
5. Li C, Heidt D G, Dalerba P etal. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67 (3): 1030-7.
6. O'Brien C A, Pollett A, Gallinger S, Dick J E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-10.
7. Prince M E, Sivanandan R, Kaczorowski A etal. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007; 104: 973-8.
8. Wang J, Guo L P, Chen L Z, Zeng Y X, Lu S H. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 2007; 67: 3716-24.
9. Sobin L H, Fleming I D. TNM classification of malignant tumors, fifth edition (1997). Cancer 1997; 80 (9): 1803-4.
10. Zeppernick F, Ahmadi R, Campos B etal. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 2008; 14 (1): 123-9.
11. Yoh K, Ishii G, Yokose T etal. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Clin Cancer Res 2004; 10 (5): 1691-7.
12. Ricci-Vitiani L, Lombardi D G, Pilozzi E etal. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-15.
13. Shepherd C J, Rizzo S, Ledaki I etal. Expression profiling of CD133+ and CD133- epithelial cells from human prostate. Prostate 2008; 68 (9): 1007-24.
14. Eramo A, Lotti F, Sette G etal. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15 (3): 504-14.
15. Ma S, Chan K W, Hu L etal. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007; 132: 2542-56.
16. Rebetz J, Tian D P, Persson A etal. Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma. PLoS ONE 2008; 3 (4): e1936.
17. Takao S, Maeda S, Shinchi H etal. CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer 2008; 98 (8): 1389-97.
18. Horst D, Scheel S K, Liebmann S etal. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol 2009; 219 (4): 427-34.
19. Kim H, Joo K M, Kim S Y etal. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 2008; 88 (8): 808-15.
20. Rafii S, Shmelkov S V, Butler J M etal. CD133 expression is not restricted to stem cells, and both CD133(+) and CD133(-) metastatic colon cancer cells initiate tumors. J Clin Invest 2008; 118: 2111-20.
21. Wang J, Sakariassen P O, Tsinkalovsky O etal. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 2008; 122 (4): 761-8.
22. Molven A, Immervoll H, Hoem D, Sakariassen P O, Steffensen O J. Expression of the 'stem cell marker' CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer 2008; 8: 48.
23. Kim K J, Lee K H, Kim H S etal. The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology 2011; 31: 494-502.
24. Kojima M, Ishii G, Atsumi N, Fujii S, Saito N, Ochiai A. Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study. Cancer Sci 2008; 99 (8): 1578-83.
25. Fan L, He F, Liu H etal. CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer 2011; 11: 320.
26. Torok-Storb B, Scharenberg C W, Harkey M A. The ABCG2 transporter is an efficient hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002; 99 (2): 507-12.
27. Hirschmann-Jax C, Foster A E, Wulf G G etal. A distinct 'side population' of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 2004; 101: 14228-33.
28. Mori M, Haraguchi N, Utsunomiya T etal. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006; 24 (3): 506-13.
29. Hung J Y, Ho M M, Ng A V, Lam S. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007; 67: 4827-33.
30. Lu S H, Huang D Z, Gao Q L etal. Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev 2009; 18 (3): 465-73.